---
figid: PMC2518073__JCI0834739.f8
figlink: /pmc/articles/PMC2518073/figure/F8/
number: F8
caption: Briefly, mTORC1 activation leads to PI3K and MAPK inhibition through a negative
  feedback loop stemming from S6K1 (left panel), while treatment with mTORC1 inhibitors
  results in a hyperactive RTK/IRS-1/PI3K pathway, increasing the signal toward the
  Ras-Raf1-MEK1/2-ERK pathway (middle panel). Therefore, the combination of MEK and
  mTORC1 inhibitors may provide a therapeutic benefit in the treatment of certain
  cancers through the abrogation of the feedback described in this study (right panel).
  Activated proteins are represented with blue circles and inhibition status with
  red squares.
pmcid: PMC2518073
papertitle: Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent
  feedback loop in human cancer.
reftext: Arkaitz Carracedo, et al. J Clin Invest. 2008 Sep 2;118(9):3065-3074.
pmc_ranked_result_index: '61195'
pathway_score: 0.8984913
filename: JCI0834739.f8.jpg
figtitle: Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent
  feedback loop in human cancer
year: '2008'
organisms: Homo sapiens
ndex: 36af6c11-df13-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2518073__JCI0834739.f8.html
  '@type': Dataset
  description: Briefly, mTORC1 activation leads to PI3K and MAPK inhibition through
    a negative feedback loop stemming from S6K1 (left panel), while treatment with
    mTORC1 inhibitors results in a hyperactive RTK/IRS-1/PI3K pathway, increasing
    the signal toward the Ras-Raf1-MEK1/2-ERK pathway (middle panel). Therefore, the
    combination of MEK and mTORC1 inhibitors may provide a therapeutic benefit in
    the treatment of certain cancers through the abrogation of the feedback described
    in this study (right panel). Activated proteins are represented with blue circles
    and inhibition status with red squares.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RHEB
  - RPS6KB1
  - TSC1
  - MAP2K2
  - PIK3R5
  - SLC22A12
  - PIK3CB
  - HRAS
  - MTOR
  - PDK1
  - NRAS
  - PIK3R6
  - MAP2K1
  - PIK3R4
  - RPTOR
  - PIK3CA
  - MAPK3
  - PIK3CD
  - MAPK1
  - KRAS
  - RAF1
  - TSC2
  - AKT3
  - IRS1
  - AKT1
  - PIK3CG
  - PIK3R3
  - AKT2
  - FKBP8
  - Rapamycin
  - Cancer
genes:
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: TSC1/2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RST
  symbol: RST
  source: hgnc_alias_symbol
  hgnc_symbol: SLC22A12
  entrez: '116085'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Raf1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: TSC1/2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: IRS1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: FKBP38
  symbol: FKBP38
  source: hgnc_alias_symbol
  hgnc_symbol: FKBP8
  entrez: '23770'
chemicals:
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC2518073__F8
redirect_from: /figures/PMC2518073__F8
figtype: Figure
---
